Company Filing History:
Years Active: 2002-2003
Title: Stanford Mark Moran: Innovator in Medical Treatments
Introduction
Stanford Mark Moran is a notable inventor based in Orinda, CA (US). He has made significant contributions to the field of medical treatments, particularly in the area of proliferative disorders. With a total of 2 patents, his work focuses on enhancing therapeutic methods while minimizing adverse effects.
Latest Patents
Moran's latest patents include innovative methods for treating proliferative disorders. One of his key inventions is a method and composition for preserving or enhancing the beneficial effects of interleukin-2 (IL-2) while simultaneously mitigating its adverse effects. This method involves administering a leukotriene B (LTB) antagonist to subjects experiencing negative pharmacological effects due to exogenous IL-2. The administration of this antagonist is designed to decrease the adverse effects induced by IL-2, thereby improving the therapeutic index of IL-2. Additionally, the patent includes a manufacturing article comprising a composition of the leukotriene B antagonist along with labeling instructions for treatment.
Career Highlights
Stanford Mark Moran is associated with Biomedicines, Inc., where he continues to develop and refine his innovative medical treatments. His work has the potential to significantly impact the therapeutic landscape for patients suffering from various proliferative disorders.
Conclusion
Stanford Mark Moran's contributions to medical innovation demonstrate his commitment to improving patient outcomes through advanced treatment methods. His patents reflect a deep understanding of the complexities involved in medical therapies, particularly in enhancing the efficacy of interleukin-2 while reducing its adverse effects.